Search clinical trials for: Adrenergic Uptake Inhibitors

Total 70660 results

National Institute on Drug Abuse (NIDA)

Completed

Neurobiology and Pharmacokinets of Acute MDMA Administration

Substance-Related Disorders

United States
Pfizer

Completed

A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.

Fibromyalgia

Canada, United States
The Cleveland Clinic

Completed

Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI

Bipolar Disorder | Major Depression

United States
Bausch Health Americas, Inc.

Withdrawn

A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome (TBZ-MR)

Tourette's Syndrome
University of Kentucky
National Institute on Drug Abuse (NIDA)

Completed

Topiramate-Phentermine Combinations for Cocaine Dependence

Cocaine Use Disorder

United States
Janssen-Cilag International NV

Withdrawn

A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression

Depressive Disorder, Treatment-Resistant
Imperial College London

Unknown

Bristol Imperial MDMA in Alcoholism Study (BIMA)

Alcohol Use Disorder

United Kingdom
Janssen Research & Development, LLC

Completed

A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine

Attention Deficit Disorder With Hyperactivity

United States
Grünenthal GmbH
Janssen Research & Development, LLC

Completed

Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain

Postoperative Pain | Acute Pain

United States
Grünenthal GmbH

Terminated

Tapentadol in Chronic Malignant Tumour Related Pain

Pain | Cancer | Chronic Pain

Bulgaria, Hungary, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine

Pain | Tumor

Austria, Bulgaria, Croatia, Czechia, France, Germany, Hungary, Italy, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, Slovakia, Spain, Sweden
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Terminated

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

Pain | Cancer | Neoplasm

United States, Argentina, Chile, France, Latvia, Ukraine
Grünenthal GmbH

Completed

Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin

Low Back Pain | Neuropathic Pain

Austria, Belgium, Denmark, Germany, Netherlands, Poland, Spain
Grünenthal GmbH

Completed

Intravenous Tapentadol in Post-Bunionectomy Pain

Pain | Bunion

United States
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy

Hysterectomy | Postoperative

Russian Federation, Hungary, Latvia, Poland, Romania, Serbia, Slovakia, Slovenia, Ukraine
Grünenthal GmbH

Completed

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking Either WHO Step I or Step II Analgesics or no Regular Analgesic

Osteoarthritis | Chronic Pain

Germany, United Kingdom, France, Poland, Spain
Grünenthal GmbH

Terminated

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Pain Due to Osteoarthritis Taking WHO Step III Analgesics But Showing a Lack of Tolerability.

Osteoarthritis | Chronic Pain

Germany, United Kingdom, Spain, Australia, Denmark, Poland
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Pain | Knee Osteoarthritis

Austria, Croatia, Germany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Slovakia, Spain, United Kingdom
Darren P Casey
Neogenis Laboratories

Completed

Dietary Nitrate and Physiological Aging

Aging

United States
Oregon Health and Science University
Portland VA Medical Center

Completed

Pilot Study of Entacapone for Methamphetamine Abuse

Methamphetamine Dependence

United States
Grünenthal GmbH

Completed

A Study to Look at Tapentadol Tablets in Children and Adolescents in Pain

Pain

Belgium, Bulgaria, Chile, France, Germany, Hungary, Italy, Portugal, Spain, United Kingdom
University of Maryland, Baltimore
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q4-Atomoxetine

Type 1 Diabetes

United States
Tonix Pharmaceuticals, Inc.

Completed

A Comparative Bioavailability and Pharmacokinetic Study of TNX-102 2.4 mg and Cyclobenzaprine 5 mg Tablets in Healthy Adults.

Healthy

Canada
Medical University of Vienna

Unknown

Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)

Major Depressive Disorder

Austria
Qingdao University

Unknown

The Effect of Negatively Fluid Balancing Speed for ICU Patients With Acute Respiratory Distress Syndrome

Fluid Loss

China
Xijing Hospital

Unknown

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder (ADHD) | Neurofeedback

China
Massachusetts General Hospital
Eli Lilly and Company

Completed

Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)

ADHD NOS

United States
University of Maryland, Baltimore

Completed

Atomoxetine as an Adjunct to Novel Antipsychotic Medication in the Treatment of Cognitive Deficits of Schizophrenia

Schizophrenia

United States
First Affiliated Hospital of Zhejiang University
Hunan DongtingPharm.Co.Ltd

Completed

Bioavailability Study of Amitriptyline Hydrochloride Tablets (AMTL-BE)

Depressive Disorder

China
United States Army Aeromedical Research Laboratory

Unknown

Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants

Cognition

United States
Emory University
National Institute on Aging (NIA)

Completed

Effects of Atomoxetine in Mild Cognitive Impairment (ATX-001)

Mild Cognitive Impairment

United States
Tris Pharma, Inc.

Completed

Dyanavel® XR Extended-Release Oral Suspension in the Treatment of Children With ADHD: A Laboratory School Study

Attention Deficit Hyperactivity Disorder

United States
University of Utah

Terminated

Amitriptyline in Treating Hypoglycemia

Type1 Diabetes Mellitus | Hypoglycemia Unawareness

United States
Celgene

Completed

Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response

Healthy Volunteer

United States
Tonix Pharmaceuticals, Inc.

Completed

Bioequivalence Study of TNX-102 SL 2.8 mg Sublingual Tablets From Two Manufacturers.

Healthy Adults

Canada
Hennepin Healthcare Research Institute

Completed

Utility of Olanzapine in the Treatment of Opioid Withdrawal in the ED

Substance Withdrawal Syndrome

United States
Asan Medical Center

Unknown

Identification of Neuropsychological, Genetic and Neuroimaging Markers and Treatment Response Predictors of ADHD

Attention Deficit Disorder With Hyperactivity

Korea, Republic of
Gil Yosipovitch

Terminated

Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine

Pruritus

United States
Vanderbilt University
Duke University

Completed

Decision Making Study in Young and Middle-Aged Adults: Part II (DND)

Healthy Adults

United States
Tris Pharma, Inc.

Completed

Pharmacokinetic Study of DYANAVEL XR (Amphetamine) Extended-release Oral Suspension, in Children Aged 4 to 5 Years

Attention Deficit Hyperactivity Disorder

United States
Fayoum University

Completed

Influence of Luting Cement on the Clinical Outcomes of Zirconia Pediatric Crowns

Deep Caries
National Rehabilitation Center, Seoul, Korea

Unknown

Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke

Stroke

Korea, Republic of
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)

Pharmacokinetic

Belgium
Second Affiliated Hospital, School of Medicine,...

Unknown

MRI Study of Antidepressants in the Treatment of Refractory Functional Dyspepsia

Therapeutic Mechanism of Antidepressants for Refractory FD

China
New York State Psychiatric Institute

Completed

Dichotic Listening as a Predictor of Medication Response in Depression

Major Depression | Dysthymia | Depressive Disorder Not Otherwise Specified

United States
Mayo Clinic

Withdrawn

A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension

Pulmonary Artery Hypertension

United States
Grünenthal GmbH

Completed

Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers

Pharmacokinetics

Germany
Grünenthal GmbH

Completed

Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women

Prolonged QTc Interval | Pharmacokinetic

Germany
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence (CAMP)

Cocaine Dependence | Adult Attention Deficit Hyperactivity Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) (Atom)

Cocaine-Related Disorders | Attention Deficit Disorder With Hyperactivity

United States

Search clinical trials for: Adrenergic Uptake Inhibitors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations